Parkinson's Disease clinical trials in California
64 active Parkinson's Disease trials with a site in California. Describe your situation to see which ones look like a fit.
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator
- Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Dual Frequency Stimulation in Parkinson's Disease
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease
- Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
- Ketamine for Veterans With Parkinson's Disease
- A Study of Buntanetap in Participants With PD
- Use of CereGate Therapy for Freezing of Gait in PD
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)
- Psilocybin Therapy for Depression in Parkinson's Disease
- Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Blood Pressure Effects on Cognition and Brain Blood Flow in PD
- Real-Time Levodopa Level Monitoring in Parkinson Disease
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Parkinson Progression Marker Initiative Online (PPMI Online)
- Parkinson's Foundation PD GENEration Genetic Registry
- Registry of Deep Brain Stimulation With the VERCISEā¢ System: Vercise DBS Registry
- GBPDC: Gut-Brain in PD Consortium Master Protocol
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
- Understanding Motivation in Parkinson's Patients Through Neurophysiology
- Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease
- Vibrotactile Coordinated Reset for the Treatment of Post Surgery Refractory Parkinson's Disease Patients
- Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population
- Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
- Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study
- Smartshoes for Freezing of Gait in Parkinson's Disease
- Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease
- Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
- Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
- A High-density Microelectrode for Human Neuronal Recordings
- Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down ā and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest ā what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.